Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Oct 15, 2024; 16(10): 4194-4208
Published online Oct 15, 2024. doi: 10.4251/wjgo.v16.i10.4194
Published online Oct 15, 2024. doi: 10.4251/wjgo.v16.i10.4194
Figure 1 Steroid receptor RNA activator 1 expression level was decreased in human esophageal squamous cell carcinoma tissues and cell lines.
A: The five pairs of esophageal squamous cell carcinoma (ESCC) and adjacent normal tissues were carried out long non-coding RNA (LncRNA) microarray analysis, and the lncRNA expression patterns were performed through hierarchical clustering; B: Changes in the lncRNA level were displayed in the volcano plot; C: LncRNA SRA1 had the highest fold of differential expression; D: Steroid receptor RNA activator 1 (SRA1) expression was apparently downregulated in ESCC tissues; E: SRA1 expression was apparently downregulated in ESCC cell line; F: ESCC patients with low SRA1 expression had shorter overall survival than patients with high SRA1 expression. aP < 0.01; bP < 0.05 vs Het-1A; cP < 0.01 vs Het-1A; LncRNA: Long non-coding RNA; SRA1: Steroid receptor RNA activator 1.
- Citation: He M, Qi Y, Zheng ZM, Sha M, Zhao X, Chen YR, Chen ZH, Qian RY, Yao J, Yang ZD. Long noncoding RNA steroid receptor RNA activator 1 inhibits proliferation and glycolysis of esophageal squamous cell carcinoma. World J Gastrointest Oncol 2024; 16(10): 4194-4208
- URL: https://www.wjgnet.com/1948-5204/full/v16/i10/4194.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i10.4194